These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
628 related articles for article (PubMed ID: 10353739)
1. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Giri D; Ropiquet F; Ittmann M Clin Cancer Res; 1999 May; 5(5):1063-71. PubMed ID: 10353739 [TBL] [Abstract][Full Text] [Related]
2. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation. Rosini P; Bonaccorsi L; Baldi E; Chiasserini C; Forti G; De Chiara G; Lucibello M; Mongiat M; Iozzo RV; Garaci E; Cozzolino F; Torcia MG Prostate; 2002 Dec; 53(4):310-21. PubMed ID: 12430142 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice. Arbeit JM; Olson DC; Hanahan D Oncogene; 1996 Nov; 13(9):1847-57. PubMed ID: 8934530 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. Ropiquet F; Giri D; Kwabi-Addo B; Mansukhani A; Ittmann M Cancer Res; 2000 Aug; 60(15):4245-50. PubMed ID: 10945637 [TBL] [Abstract][Full Text] [Related]
6. Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors. Wu X; Jin C; Wang F; Yu C; McKeehan WL Cancer Res; 2003 Aug; 63(16):4936-44. PubMed ID: 12941818 [TBL] [Abstract][Full Text] [Related]
7. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. Ittman M; Mansukhani A J Urol; 1997 Jan; 157(1):351-6. PubMed ID: 8976296 [TBL] [Abstract][Full Text] [Related]
8. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. Freeman KW; Gangula RD; Welm BE; Ozen M; Foster BA; Rosen JM; Ittmann M; Greenberg NM; Spencer DM Cancer Res; 2003 Oct; 63(19):6237-43. PubMed ID: 14559809 [TBL] [Abstract][Full Text] [Related]
9. The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. Wang J; Stockton DW; Ittmann M Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6169-78. PubMed ID: 15448004 [TBL] [Abstract][Full Text] [Related]
10. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2. Billottet C; Janji B; Thiery JP; Jouanneau J Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548 [TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Polnaszek N; Kwabi-Addo B; Peterson LE; Ozen M; Greenberg NM; Ortega S; Basilico C; Ittmann M Cancer Res; 2003 Sep; 63(18):5754-60. PubMed ID: 14522896 [TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer. Carstens RP; Eaton JV; Krigman HR; Walther PJ; Garcia-Blanco MA Oncogene; 1997 Dec; 15(25):3059-65. PubMed ID: 9444954 [TBL] [Abstract][Full Text] [Related]
13. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors. Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666 [TBL] [Abstract][Full Text] [Related]
14. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Tannheimer SL; Rehemtulla A; Ethier SP Breast Cancer Res; 2000; 2(4):311-20. PubMed ID: 11056689 [TBL] [Abstract][Full Text] [Related]
15. The role of fibroblast growth factors and their receptors in prostate cancer. Kwabi-Addo B; Ozen M; Ittmann M Endocr Relat Cancer; 2004 Dec; 11(4):709-24. PubMed ID: 15613447 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Auguste P; Gürsel DB; Lemière S; Reimers D; Cuevas P; Carceller F; Di Santo JP; Bikfalvi A Cancer Res; 2001 Feb; 61(4):1717-26. PubMed ID: 11245488 [TBL] [Abstract][Full Text] [Related]
17. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Kwabi-Addo B; Wang J; Erdem H; Vaid A; Castro P; Ayala G; Ittmann M Cancer Res; 2004 Jul; 64(14):4728-35. PubMed ID: 15256439 [TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells. Feng S; Wang F; Matsubara A; Kan M; McKeehan WL Cancer Res; 1997 Dec; 57(23):5369-78. PubMed ID: 9393762 [TBL] [Abstract][Full Text] [Related]
19. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. Giri D; Ropiquet F; Ittmann M J Cell Physiol; 1999 Jul; 180(1):53-60. PubMed ID: 10362017 [TBL] [Abstract][Full Text] [Related]
20. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. Ropiquet F; Giri D; Lamb DJ; Ittmann M J Urol; 1999 Aug; 162(2):595-9. PubMed ID: 10411093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]